Macular Degeneration Home > Lucentis and Breastfeeding
No clinical studies have been conducted on Lucentis and breastfeeding. However, the medicine is used to treat a condition that generally affects older people, so it is not likely that a young woman would need to take it. Since nursing infants may develop serious problems when exposed to Lucentis, breastfeeding women taking the drug should watch for side effects in their child.
Currently, it is not known if Lucentis® (ranibizumab) passes through breast milk in women. If it does pass through breast milk, it might cause problems in a breastfed infant. Therefore, if you are breastfeeding or thinking of starting, make sure to let your healthcare provider know.
No studies have been conducted on whether Lucentis passes through breast milk, probably because it is used to treat macular degeneration, which primarily affects older people. If the drug does pass though breast milk, however, it could cause serious problems. If your healthcare provider recommends taking Lucentis while breastfeeding, be sure to watch for any side effects in your child.
You should talk with your healthcare provider about Lucentis and breastfeeding. Everyone's situation is different, and your healthcare provider understands your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Lucentis and breastfeeding that is right for you.